Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.2M Sell
92,014
-43,510
-32% -$2.9M 0.03% 448
2026
Q1
$8.51M Sell
135,524
-9,724
-7% -$677K 0.04% 388
2025
Q4
$9.64M Buy
145,248
+138,996
+2,223% +$8.99M 0.03% 357
2025
Q3
$421K Sell
6,252
-45,073
-88% -$3.57M ﹤0.01% 1381
2025
Q2
$4.48M Sell
51,325
-12,856
-20% -$1.01M 0.03% 451
2025
Q1
$4.38M Buy
64,181
+11,437
+22% +$933K 0.03% 378
2024
Q4
$4.1M Buy
52,744
+31,641
+150% +$2.34M 0.04% 314
2024
Q3
$1.41M Buy
21,103
+354
+2% +$29.1K 0.02% 449
2024
Q2
$2.35M Buy
20,749
+730
+4% +$92.3K 0.03% 306
2024
Q1
$2.78M Buy
20,019
+1,421
+8% +$179K 0.04% 263
2023
Q4
$2.31M Sell
18,598
-468
-2% -$47.8K 0.04% 267
2023
Q3
$1.78M Sell
19,066
-1,550
-8% -$175K 0.04% 284
2023
Q2
$2.65M Buy
20,616
+931
+5% +$113K 0.05% 222
2023
Q1
$2.29M Sell
19,685
-928
-5% -$104K 0.05% 230
2022
Q4
$2.33M Buy
20,613
+2,066
+11% +$227K 0.07% 215
2022
Q3
$1.49M Sell
18,547
-3,971
-18% -$336K 0.04% 277
2022
Q2
$1.68M Buy
22,518
+15,178
+207% +$1.39M 0.05% 227
2022
Q1
$939K Buy
7,340
+668
+10% +$73.1K 0.02% 342
2021
Q4
$896K Buy
6,672
+916
+16% +$132K 0.02% 329
2021
Q3
$787K Buy
5,756
+2,896
+101% +$365K 0.02% 329
2021
Q2
$305K Buy
+2,860
New +$275K 0.01% 458

Other funds holding DXCM

IEQ Capital's DXCM Position: Q2 2026 in Review

IEQ Capital reduced its DexCom (DXCM) stake by 32% in Q2 2026, selling an estimated $2.9M and leaving 92,014 shares worth $6.2M. The position accounts for 0.03% of the portfolio, ranked #448.

IEQ Capital first reported a position in DXCM in Q2 2021 and has held it in 21 quarters since. The position peaked at $9.64M in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • IEQ Capital held 92,014 shares of DexCom worth $6.2M as of Q2 2026.
  • IEQ Capital sold 43,510 DexCom shares in Q2 2026, an estimated $2.9M.
  • DexCom made up 0.03% of IEQ Capital's portfolio in Q2 2026, its #448 holding.
  • IEQ Capital first reported a position in DexCom in Q2 2021 and has held it in 21 quarters since.
  • IEQ Capital's DexCom position peaked at $9.64M in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.